Attorneys for Defendants Watson Laboratories, Inc. and Watson Pharmaceuticals, Inc.
|
|
- Tracey McDaniel
- 6 years ago
- Views:
Transcription
1 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 1 of 14 HELLRING LINDEMAN GOLDSTEIN & SIEGAL LLP Matthew E. Moloshok, Esq. Robert S. Raymar, Esq. One Gateway Center Newark, New Jersey Telephone: ( Facsimile: ( mmoloshok@hlgslaw.com rsraymar@hlgslaw.com Attorneys for Defendants Watson Laboratories, Inc. and Watson Pharmaceuticals, Inc. UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY TEVA WOMEN'S HEALTH, INC., Plaintiff, v. Civil Action No. 2:10-CV FSH-PS LUPIN, LTD., LUPIN PHARMACEUTICALS, INC., WATSON LABORATORIES, INC. AND ELECTRONICALLY FILED WATSON PHARMACEUTICALS, INC., Defendants. ANSWER, AFFIRMATIVE DEFENSES AND COUNTERCLAIMS OF DEFENDANTS WATSON LABORATORIES, INC. AND WATSON PHARMACEUTICALS, INC. TO TEVA WOMEN S HEALTH, INC. S COMPLAINT Defendants Watson Laboratories, Inc. ( Watson Laboratories and Watson Pharmaceuticals, Inc. ( Watson Pharmaceuticals (collectively, Watson, by and through the undersigned attorneys, answer the complaint for patent infringement ( Complaint of plaintiff, Teva Women s Health, Inc. ( Teva Women s Health, as follows: NATURE OF THE ACTION 1. Responding to paragraph 1 of the Complaint, Watson admits only that this action for alleged patent infringement purports to arise under the Patent Laws of the United States. All other allegations of paragraph 1 of the Complaint are denied.
2 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 2 of 14 THE PARTIES 2. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 2 of the Complaint and, therefore, denies them. 3. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 3 of the Complaint and, therefore, denies them. 4. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 4 of the Complaint and, therefore, denies them. 5. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 5 of the Complaint and, therefore, denies them. 6. Responding to paragraph 6 of the Complaint, Watson admits only that Watson Pharmaceuticals is a corporation organized and existing under the laws of the State of Nevada. All other allegations of paragraph 6 of the Complaint are denied. 7. Responding to paragraph 7 of the Complaint, Watson admits only that Watson Laboratories is a corporation organized and existing under the laws of the State of Nevada. All other allegations of paragraph 7 of the Complaint are denied. 8. Responding to paragraph 8 of the Complaint, Watson admits only that Watson Laboratories is a wholly-owned subsidiary of Watson Pharmaceuticals and the two have common officers and a common director. All other allegations of paragraph 8 of the Complaint are denied. 9. Responding to paragraph 9 of the Complaint, Watson admits that Watson Laboratories develops and manufactures generic pharmaceutical products, including generic contraceptive products. All other allegations of paragraph 9 of the Complaint are denied. JURISDICTION AND VENUE 10. Responding to paragraph 10 of the Complaint, Watson admits this Court has subject matter jurisdiction pursuant to 28 U.S.C. 1331, 1338(a. 11. Responding to paragraph 11 of the Complaint, Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations relating to co-defendants Lupin 2
3 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 3 of 14 Ltd. and Lupin Pharmaceuticals, Inc. (collectively, Lupin and, therefore, denies them. All other allegations of paragraph 11 of the Complaint are denied. 12. Responding to paragraph 12 of the Complaint, Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations relating to Lupin and, therefore, denies them. All other allegations of paragraph 12 of the Complaint are denied. BACKGROUND 13. Responding to paragraph 13 of the Complaint, Watson admits only that a copy of U.S. Patent No. 7,615,545 B2 ( the 545 patent is attached to Teva Women s Health s Complaint as Exhibit A; that the cover page of the 545 patent recites Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology and identifies Robert G. Bell, Carole Ben-Maimon, and Beata Iskold as the inventors, and Duramed Pharmaceuticals, Inc. as the assignee; and that the cover page further recites an issuance date of November 10, Watson denies that the 545 patent was duly and legally issued. Watson further denies that [t]he 545 patent is valid and enforceable. As to the remainder of the allegations in paragraph 13 of the Complaint, Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations and, therefore, denies them. 14. Responding to paragraph 14 of the Complaint, the 545 patent speaks for itself. As to the characterizations and remaining allegations in paragraph 14 of the Complaint, Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations and, therefore, denies them. 15. Responding to paragraph 15 of the Complaint, the LoSeasonique product speaks for itself with respect to the contents of its active ingredients. As to the characterizations and remaining allegations in paragraph 15 of the Complaint, Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations and, therefore, denies them. 16. Responding to paragraph 16 of the Complaint, Watson admits only that the 545 patent is listed in the FDA publication titled Approved Drug Products with Therapeutic 3
4 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 4 of 14 Equivalence Evaluations (known as the Orange Book in connection with NDA No for LoSeasonique. All other allegations of paragraph 16 of the Complaint are denied. LUPIN S ACTS GIVING RISE TO THIS ACTION 17. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 17 of the Complaint and, therefore, denies them. 18. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 18 of the Complaint and, therefore, denies them. 19. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 19 of the Complaint and, therefore, denies them. 20. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 20 of the Complaint and, therefore, denies them. 21. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 21 of the Complaint and, therefore, denies them. 22. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 22 of the Complaint and, therefore, denies them. 23. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 23 of the Complaint and, therefore, denies them. 24. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 24 of the Complaint and, therefore, denies them. WATSON S ACTS GIVING RISE TO THIS ACTION 25. Responding to paragraph 25 of the Complaint, Watson Laboratories admits that it submitted ANDA No to the FDA seeking approval to manufacture, sell and distribute a generic version of LoSeasonique. Watson Laboratories admits that it provided a letter dated November 23, 2009 to Duramed Pharmaceuticals, Inc., the holder of NDA No for LoSeasonique ( Notice Letter, as required by 21 U.S.C. 355(j(2(B. All other allegations of paragraph 25 of the Complaint are denied. 4
5 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 5 of Responding to paragraph 26 of the Complaint, Watson Laboratories Notice Letter speaks for itself and any additional characterizations thereof beyond the plain language are denied. All other allegations of paragraph 26 of the Complaint are denied. 27. Responding to paragraph 27 of the Complaint, Watson Laboratories admits that its ANDA No contains a certification, pursuant to 21 U.S.C. 355(j(2(A(vii(IV, that the 545 patent is invalid, unenforceable and/or will not be infringed by the manufacture, use or sale of its proposed ANDA product. Watson Laboratories denies that the commercial manufacture, use, offer for sale, sale and/or importation of its proposed ANDA product would infringe any valid and enforceable claim of the 545 patent. All other allegations of paragraph 27 of the Complaint are denied. 28. Responding to paragraph 28 of the Complaint, Watson Laboratories Notice Letter speaks for itself and additional characterizations thereof beyond the plain language are denied. All other allegations of paragraph 28 of the Complaint are denied. 29. Responding to paragraph 29 of the Complaint, Watson Laboratories Notice Letter speaks for itself and additional characterizations thereof beyond the plain language are denied. All other allegations of paragraph 29 of the Complaint are denied. 30. Responding to paragraph 30 of the Complaint, Watson Laboratories admits that it submitted ANDA No to the FDA seeking approval to engage in the commercial manufacture, use or sale of its proposed ANDA product. All other allegations of paragraph 30 of the Complaint are denied. 31. Responding to paragraph 31 of the Complaint, Watson admits only that it was aware of the 545 patent when Watson Laboratories submitted its Paragraph IV certification directed to this patent. All other allegations of paragraph 31 of the Complaint are denied. 32. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 32 of the Complaint and, therefore, denies them. 5
6 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 6 of 14 ANSWERING COUNT I: PATENT INFRINGEMENT OF U.S. PATENT NO. 7,615,545 Answering Lupin s Infringement 33. Responding to paragraph 33 of the Complaint, Watson hereby incorporates by reference its answers, in their entirety, set forth in paragraphs 1-32 of this Answer. 34. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 34 of the Complaint and, therefore, denies them. 35. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 35 of the Complaint and, therefore, denies them. 36. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 36 of the Complaint and, therefore, denies them. 37. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 37 of the Complaint and, therefore, denies them. 38. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 38 of the Complaint and, therefore, denies them. 39. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 39 of the Complaint and, therefore, denies them. 40. Watson lacks sufficient knowledge or information to form a belief as to the truth of the allegations of paragraph 40 of the Complaint and, therefore, denies them. Answering Watson s Infringement 41. Watson denies each and every allegation of paragraph 41 of the Complaint. 42. Watson denies each and every allegation of paragraph 42 of the Complaint. 43. Watson denies each and every allegation of paragraph 43 of the Complaint. 44. Watson denies each and every allegation of paragraph 44 of the Complaint. 45. Watson denies each and every allegation of paragraph 45 of the Complaint. 46. Watson denies each and every allegation of paragraph 46 of the Complaint. 47. Watson denies each and every allegation of paragraph 47 of the Complaint. 6
7 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 7 of 14 Answering PRAYER FOR RELIEF Except as specifically admitted herein, Watson denies each and every allegation contained in the Complaint, and denies that Teva Women s Health is entitled to any of the relief requested or to any relief whatsoever. AFFIRMATIVE DEFENSES First Affirmative Defense (Lack of Subject Matter Jurisdiction This Court lacks subject matter jurisdiction because Watson Pharmaceuticals, Inc. is not a proper party to this Complaint as it did not submit ANDA No , which is the ANDA at issue. Second Affirmative Defense (Failure to State a Claim for Relief The Complaint fails to state a claim for relief against Watson Pharmaceuticals, Inc., as it did not submit ANDA No , which is the ANDA at issue. Third Affirmative Defense (The Claims of the 545 Patent Are Not Infringed Watson Laboratories submission of its ANDA No for the purpose of obtaining approval to market a generic version of LoSeasonique did not and does not infringe any valid and enforceable claim of the 545 patent under 35 U.S.C. 271(e(2, nor would the manufacture, use, sale, offer of sale in and/or importation into the United States of Watson Laboratories proposed generic version of LoSeasonique that is the subject of ANDA No infringe any valid and enforceable claim of the 545 patent. Fourth Affirmative Defense (The Claims of the 545 Patent Are Invalid for Anticipation The claims of the 545 patent are invalid because the alleged inventions claimed therein are anticipated in view of the prior art to one having ordinary skill in the art and thus fail to satisfy the conditions for patentability set forth in 35 U.S.C
8 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 8 of 14 Fifth Affirmative Defense (The Claims of the 545 Patent Are Invalid For Obviousness The claims of the 545 patent are invalid because the alleged inventions claimed therein are obvious in view of the prior art to one having ordinary skill in the art and thus fail to satisfy the conditions for patentability set forth in 35 U.S.C Sixth Affirmative Defense (Failure to State a Claim for Relief To the extent Teva Women s Health alleges that Watson Laboratories submission of ANDA No makes this an exceptional case under 35 U.S.C. 285, the Complaint fails to state a claim upon which relief can be granted and it must be dismissed. COUNTERCLAIM FOR DECLARATORY JUDGMENT Defendant/Counter-Plaintiff, Watson Laboratories, Inc. ( Watson Laboratories, conditionally brings the following Counterclaims against Plaintiff/Counter-Defendant Teva Women s Health ( Teva Women s Health : PARTIES 1. Defendant/Counter-Plaintiff Watson Laboratories is a corporation organized and existing under the laws of the State of Nevada, having a principal place of business at 311 Bonnie Circle, Corona, California Upon information and belief, Plaintiff/Counter-Defendant Teva Women s Health is a corporation organized and existing under the laws of the State of Delaware, having an established place of business at 400 Chestnut Ridge Road, Woodcliff Lake, New Jersey
9 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 9 of 14 BACKGROUND A. FDA Approval of Brand-Name Drugs 3. The Federal Food, Drug, and Cosmetic Act ( FFDCA, 21 U.S.C. 301 et seq., as amended by the Hatch-Waxman Act (described below as further amended by the Medicare Prescription Drug, Improvement and Modernization Act ( MMA, sets forth the rules that the U.S. Food and Drug Administration ( FDA follows when considering whether to approve the marketing of both brand-name and generic drugs. 4. Under the FFDCA, an applicant seeking to market a new brand-name drug must prepare a New Drug Application ( NDA for consideration by the FDA. See 21 U.S.C A NDA must include, inter alia, the number of any patent that claims the drug or a method of using such drug for which the NDA was submitted and for which a claim of patent infringement could reasonably be asserted against a person not licensed by the patent owner to engage in the manufacture, use, or sale of the drug. See 21 U.S.C. 355(b(1, (c(2; 21 C.F.R (b, (c(2. 6. Upon approval of the NDA, the FDA publishes patent information for the approved drug in the Approved Drug Products with Therapeutic Equivalence Evaluations, commonly referred to as the Electronic Orange Book or Orange Book. See 21 U.S.C. 355(j(7(A(iii. B. Generic Competition Approval of Abbreviated New Drug Applications 7. Generic drugs are versions of brand-name drugs that contain the same active ingredients, but not necessarily the same inactive ingredients, as the brand-name original. 8. In 1984, Congress enacted the Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, to the FFDCA. See Pub. L. No , 98 Stat (1984 (codified at 21 U.S.C. 355 and 35 U.S.C. 156, 271(e. The Hatch- Waxman Act simplified the process for obtaining approval of generic drugs, for at least the purpose of decreasing the cost of pharmaceuticals through early market entry of generic drugs. 9
10 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 10 of 14 Under the Hatch-Waxman Act, a generic manufacturer submits what is called an Abbreviated New Drug Application ( ANDA. 9. To receive approval of its ANDA, a generic manufacturer must show, inter alia, that its generic drug is bioequivalent to the listed reference drug. See 21 U.S.C. 355(j(4(F. 10. An ANDA must also contain a certification as to every patent that the NDA holder caused to be listed in the Orange Book with respect to the particular approved drug for which the ANDA is being submitted. See 21 U.S.C. 355(j(2(A(vii; 21 C.F.R (a( If the generic manufacturer seeks to market its proposed generic product that is the subject of its ANDA prior to the expiration of any patent listed in the Orange Book, it must submit with its ANDA a so-called paragraph IV certification directed to the listed patent. A paragraph IV certification directed to a patent listed in the Orange Book asserts that the patent is invalid, unenforceable, and/or will not be infringed and, on that basis, the generic manufacturer seeks FDA approval for commercial marketing of the generic product prior to expiration of the patent as to which the certification is made. See 21 U.S.C. 355(j(2(A(vii(IV. 12. The generic manufacturer must also notify both the patent owner and NDA holder of its paragraph IV certification. See 21 U.S.C. 355(j(2(B(i. 13. Upon receiving notice of the paragraph IV certification, the NDA holder/patent owner can file a patent infringement suit against the generic manufacturer. See 21 U.S.C. 355(j(5(B(iii. C. Watson Laboratories, Inc. s ANDA 14. Watson Laboratories submitted an ANDA No with the FDA seeking approval to market an oral contraceptive product, referencing NDA No for LoSeasonique. 15. The holder of NDA No caused the FDA to list U.S. Patent No. 7,615,545 B2 ( the 545 patent in the Orange Book in connection with NDA No , after the patent issued on or about November 10,
11 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 11 of Because Watson Laboratories seeks FDA approval to market its generic version of LoSeasonique before expiration of the 545 patent, Watson s ANDA includes a paragraph IV certification against the 545 patent, and Watson Laboratories provided the patent owner and holder of NDA No with the required Notice under 21 U.S.C. 355(j(2(B(i on or about November 23, Watson Laboratories Notice of its paragraph IV certification provided the holder of NDA No with statutory authority, under 35 U.S.C. 271(e(2, to sue Watson Laboratories for alleged infringement of the 545 patent. 18. On information and belief, Duramed Pharmaceuticals, Inc. ( Duramed is the assignee of the 545 patent. 19. On information and belief, Teva Women s Health is the successor to, and/or was formerly known as Duramed, and Teva Women s Health is also the current holder of NDA No Teva Women s Health has filed in this Court a patent infringement action against Watson Laboratories and others alleging infringement of the 545 patent. JURISDICTION AND VENUE 21. Watson Laboratories realleges and incorporates by reference the allegations of paragraphs 1-20 of this Counterclaim. 22. This is an action under the Declaratory Judgment Act, 28 U.S.C and 2202, and the Patent Laws of the United States, based upon an actual controversy between the parties. 23. This is a compulsory counterclaim under Rule 13(a of the Federal Rules of Civil Procedure and the Court has jurisdiction pursuant to 28 U.S.C. 1331, 1338(a, 2201 and COUNTERCLAIM FOR DECLARATION OF NONINFRINGEMENT OF UNITED STATES PATENT NO. 7,615,545 B2 24. Watson Laboratories realleges and incorporates by reference the allegations of paragraphs 1-23 of this Counterclaim. 11
12 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 12 of Watson Laboratories submission of its ANDA No for the purpose of obtaining approval to market a generic version of LoSeasonique did not and does not infringe any valid and enforceable claim of the 545 patent under 35 U.S.C. 271(e(2, nor would the manufacture, use, sale, offer of sale in and/or importation into the United States of Watson Laboratories proposed generic version of LoSeasonique that is the subject of ANDA No infringe any valid and enforceable claim of the 545 patent. 26. Watson Laboratories is entitled to a declaration that the manufacture, use, sale, offer of sale in and/or importation into the United States of the product that is the subject of Watson Laboratories ANDA No would not infringe any valid and enforceable claim of the 545 patent. COUNTERCLAIM FOR DECLARATION OF INVALIDITY OF UNITED STATES PATENT NO. 7,615,545 B2 27. Watson Laboratories realleges and incorporates by reference the allegations of paragraphs 1-26 of this Counterclaim. 28. The 545 patent is invalid for failure to meet one or more of the requirements of patentability under 35 U.S.C. 101, et seq., including but not limited to 35 U.S.C. 102 and The claims of the 545 patent are invalid because the alleged inventions claimed therein are anticipated in view of the prior art to one having ordinary skill in the art and thus fail to satisfy the conditions for patentability set forth in 35 U.S.C The claims of the 545 patent are invalid because the alleged inventions claimed therein are obvious in view of the prior art to one having ordinary skill in the art and thus fail to satisfy the conditions for patentability set forth in 35 U.S.C Therefore, Watson Laboratories is entitled to a declaration that the claims of the 545 patent are invalid, including for anticipation and/or obviousness in view of the prior art. 12
13 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 13 of 14 REQUEST FOR RELIEF WHEREFORE, Defendant/Counter-Plaintiff Watson Laboratories respectfully requests that this Court enter a Judgment and Order in its favor against Plaintiff/Counter-Defendant Teva Women s Health: (a (b (c Dismissing the Complaint herein in its entirety with prejudice; Declaring that the claims of the 545 patent are invalid; Declaring that no valid and enforceable claim of the 545 patent has been infringed; (d Permanently enjoining Teva Women s Health, its officers, agents, directors, servants, employees, subsidiaries, and assigns, and all those acting under the authority of or in privy with them or with any of them, from asserting or otherwise seeking to enforce the 545 patent against either Watson Laboratories or its proposed generic version of the LoSeasonique product; (e Declaring that this case is an exceptional case under 35 U.S.C. 285 and awarding Watson Laboratories its attorney s fees, costs, and expenses; and (f Awarding Watson Laboratories any further additional relief as the Court may deem just, proper and equitable. Dated: March 1, 2010 HELLRING LINDEMAN GOLDSTEIN & SIEGAL LLP By:/s/ Matthew E. Moloshok Matthew E. Moloshok, Esq. Robert S. Raymar, Esq. One Gateway Center Newark, New Jersey Telephone: ( Facsimile: ( mmoloshok@hlgslaw.com rsraymar@hlgslaw.com 13
14 Case 2:10-cv FSH -PS Document 15 Filed 03/01/10 Page 14 of 14 Of Counsel: Mark T. Jansen, Esq. TOWNSEND AND TOWNSEND AND CREW LLP Two Embarcadero Center, 8 th Floor San Francisco, CA Telephone: ( Facsimile: ( Cedric C.Y. Tan, Esq. Kristin M. Cooklin, Esq. TOWNSEND AND TOWNSEND AND CREW LLP 1301 K Street, N.W. Ninth Floor, East Towner Washington, D.C Telephone: ( Facsimile: ( Attorneys for Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. 14
Case 2:09-cv DMC-MF Document 17 Filed 04/20/2009 Page 1 of 28 : :
Case 2:09-cv-01302-DMC-MF Document 17 Filed 04/20/2009 Page 1 of 28 WINSTON & STRAWN LLP The Legal Center One Riverfront Plaza, 7th Floor Newark, New Jersey 07102 (973) 848-7676 James S. Richter Attorneys
More informationCase 1:16-cv UNA Document 1 Filed 04/07/16 Page 1 of 17 PageID #: 1 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) ) ) ) ) ) ) ) )
Case 1:16-cv-00237-UNA Document 1 Filed 04/07/16 Page 1 of 17 PageID #: 1 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FRESENIUS KABI USA, LLC, Plaintiff, v. MAIA PHARMACEUTICALS, INC., Defendant.
More informationCase 1:09-cv JJF Document 36 Filed 02/09/10 Page 1 of 22 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:09-cv-00651-JJF Document 36 Filed 02/09/10 Page 1 of 22 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE BRISTOL-MYERS SQUIBB CO., and BRISTOL-MYERS SQUIBB PHARMA CO. Plaintiffs,
More informationCase: 1:16-cv Document #: 1 Filed: 03/09/16 Page 1 of 13 PageID #:1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION
Case: 1:16-cv-02988 Document #: 1 Filed: 03/09/16 Page 1 of 13 PageID #:1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION TORRENT PHARMACEUTICALS LIMITED, and TORRENT PHARMA
More informationCase 1:10-cv UNA Document 1 Filed 10/05/10 Page 1 of 20
Case 1:10-cv-00852-UNA Document 1 Filed 10/05/10 Page 1 of 20 Case 1:10-cv-00852-UNA Document 1 Filed 10/05/10 Page 2 of 20 4. Plaintiff Allergan Sales, LLC is a corporation organized and existing under
More informationCase 1:12-cv SLR Document 18 Filed 08/27/12 Page 1 of 17 PageID #: 71 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:12-cv-00809-SLR Document 18 Filed 08/27/12 Page 1 of 17 PageID #: 71 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE PFIZER INC., WYETH LLC, WYETH PHARMACEUTICALS INC., and PF PRISM
More informationCase 1:16-cv RBK-JS Document 1 Filed 06/30/16 Page 1 of 14 PageID: 1
Case 1:16-cv-03910-RBK-JS Document 1 Filed 06/30/16 Page 1 of 14 PageID: 1 John E. Flaherty Ravin R. Patel McCARTER & ENGLISH LLP Four Gateway Center 100 Mulberry St. Newark, NJ 07102 (973) 622-4444 Attorneys
More informationUNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY ) THE UNITED STATES OF AMERICA ) and THE BOARD OF TRUSTEES OF ) THE UNIVERSITY OF ILLINOIS, ) Civil Action No. ) Plaintiffs, ) COMPLAINT FOR ) PATENT
More informationCase 1:09-cv UNA Document 1 Filed 07/13/2009 Page 1 of 17
Case 1:09-cv-00511-UNA Document 1 Filed 07/13/2009 Page 1 of 17 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, ENDO PHARMACEUTICALS
More informationCase 2:15-cv WHW-CLW Document 1 Filed 04/10/15 Page 1 of 81 PageID: 1
Case 2:15-cv-02571-WHW-CLW Document 1 Filed 04/10/15 Page 1 of 81 PageID: 1 Walter W. Brown U.S. Department of Justice 1100 L. St. N.W. Washington, D.C. 20005 (202) 307-0341 walter.brown2@usdoj.gov Attorneys
More informationCase 2:11-cv WHW -MCA Document 7 Filed 09/12/11 Page 1 of 17 PageID: 57
Case 2:11-cv-03995-WHW -MCA Document 7 Filed 09/12/11 Page 1 of 17 PageID: 57 James E. Cecchi (JCecchi@carellabyrne.com) Melissa E. Flax (mflax@carellabyrne.com) CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY
More informationCase 3:12-cv PGS-LHG Document 1 Filed 06/25/12 Page 1 of 41 PageID: 1
Case 3:12-cv-03893-PGS-LHG Document 1 Filed 06/25/12 Page 1 of 41 PageID: 1 Liza M. Walsh CONNELL FOLEY LLP 85 Livingston Avenue Roseland, New Jersey 07068 (973) 535-0500 Of Counsel: Dimitrios T. Drivas
More informationCase 1:11-cv EGS Document 10 Filed 04/25/12 Page 1 of 13 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
Case 1:11-cv-01631-EGS Document 10 Filed 04/25/12 Page 1 of 13 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA NOVARTIS AG and NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiffs, v. Civil
More informationCase 2:12-cv WHW-MCA Document 10 Filed 07/23/12 Page 1 of 20 PageID: 141
Case 2:12-cv-02840-WHW-MCA Document 10 Filed 07/23/12 Page 1 of 20 PageID: 141 James E. Cecchi (JCecchi@carellabyrne.com Melissa E. Flax (mflax@carellabyrne.com CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY &
More informationIN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION GALDERMA LABORATORIES, L.P., GALDERMA S.A., and GALDERMA RESEARCH & DEVELOPMENT, S.N.C., v. Plaintiffs, ACTAVIS LABORATORIES
More informationCase 1:15-cv RMB-JS Document 1 Filed 10/09/15 Page 1 of 14 PageID: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 1:15-cv-07415-RMB-JS Document 1 Filed 10/09/15 Page 1 of 14 PageID: 1 John E. Flaherty Ravin R. Patel McCARTER & ENGLISH LLP Four Gateway Center 100 Mulberry Street Newark, New Jersey 07102 (973)
More informationCase 3:18-cv FLW-LHG Document 1 Filed 01/26/18 Page 1 of 25 PageID: 1
Case 3:18-cv-01097-FLW-LHG Document 1 Filed 01/26/18 Page 1 of 25 PageID: 1 Cynthia S. Betz Ravin R. Patel McCARTER & ENGLISH LLP Four Gateway Center 100 Mulberry Street Newark, New Jersey 07102 (973)
More informationCase 1:16-cv UNA Document 1 Filed 01/15/16 Page 1 of 13 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:16-cv-00015-UNA Document 1 Filed 01/15/16 Page 1 of 13 PageID #: 1 PROSTRAKAN, INC. and STRAKAN INTERNATIONAL S.á r.l., IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE v. Plaintiffs,
More informationCase 1:18-cv UNA Document 1 Filed 01/19/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00117-UNA Document 1 Filed 01/19/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TEVA PHARMACEUTICALS INTERNATIONAL GMBH, CEPHALON, INC., and EAGLE
More informationCase 1:18-cv LPS Document 1 Filed 01/12/18 Page 1 of 17 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00092-LPS Document 1 Filed 01/12/18 Page 1 of 17 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE H. LUNDBECK A/S, TAKEDA PHARMACEUTICAL COMPANY LTD., TAKEDA PHARMACEUTICALS
More informationCase 1:17-cv UNA Document 1 Filed 12/22/17 Page 1 of 10 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:17-cv-01844-UNA Document 1 Filed 12/22/17 Page 1 of 10 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE AMGEN INC., v. Plaintiff, TORRENT PHARMACEUTICALS LTD. and TORRENT
More informationCase 1:18-cv IMK Document 250 Filed 08/30/18 Page 1 of 11 PageID #: 2905 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00226-IMK Document 250 Filed 08/30/18 Page 1 of 11 PageID #: 2905 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ALLERGAN SALES, LLC, FOREST LABORATORIES HOLDINGS, LTD.,
More informationPHARMACEUTICAL LAW GROUP PC
in L PHARMACEUTICAL LAW GROUP PC AT THE INTERSECTION OF FDA REGULATION AND INTELLECTUAL PROPERTY 900 SEVENTH STREET, NW - SUITE 650 - WASHINGTON, DC 20001-3886 T 202 589 1780 F 202 318 2198 WWW.PHARMALAWGRP.COM
More informationUnited States District Court EASTERN DISTRICT OF TEXAS TYLER DIVISION
Case 6:11-cv-00441-MHS Document 304 Filed 01/13/14 Page 1 of 5 PageID #: 8335 United States District Court EASTERN DISTRICT OF TEXAS TYLER DIVISION ALLERGAN, INC. v. Cause No. 6:11-cv-441 Consolidated
More informationIN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK
Case 1:11-cv-02037-UA Document 13 Filed 06/01/11 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK ) PURDUE PHARMA L.P., ) THE P.F. LABORATORIES, INC., ) PURDUE PHARMACEUTICALS
More informationCase 1:15-cv LPS Document 118 Filed 05/10/16 Page 1 of 11 PageID #: 2856 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:15-cv-00164-LPS Document 118 Filed 05/10/16 Page 1 of 11 PageID #: 2856 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE COSMO TECHNOLOGIES LIMITED, VALEANT PHARMACEUTICALS INTERNATIONAL,
More informationCase 1:17-cv UNA Document 1 Filed 10/20/17 Page 1 of 8 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:17-cv-01481-UNA Document 1 Filed 10/20/17 Page 1 of 8 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABORATORIES, LLC, FOREST LABORATORIES HOLDINGS, LTD., ALLERGAN
More informationCase 1:16-cv UNA Document 1 Filed 09/30/16 Page 1 of 11 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:16-cv-00886-UNA Document 1 Filed 09/30/16 Page 1 of 11 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE PFIZER INC. and UCB PHARMA GMBH, v. Plaintiffs, AUROBINDO PHARMA
More informationCase 1:08-cv Document 1 Filed 02/04/2008 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS FOREST LABORATORIES, INC., FOREST LABORATORIES HOLDINGS, LTD., MERZ PHARMA GMBH & CO. KGAA, and MERZ PHARMACEUTICALS GMBH, Plaintiffs,
More informationCase 1:18-cv UNA Document 1 Filed 01/30/18 Page 1 of 8 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00171-UNA Document 1 Filed 01/30/18 Page 1 of 8 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABORATORIES HOLDINGS, LTD., ALLERGAN USA, INC., ALLERGAN
More informationCase 3:10-cv JAP -TJB Document 1 Filed 08/16/10 Page 1 of 13 PageID: 1
Case 3:10-cv-04205-JAP -TJB Document 1 Filed 08/16/10 Page 1 of 13 PageID: 1 John E. Flaherty Jonathan M.H. Short McCARTER & ENGLISH, LLP Four Gateway Center 100 Mulberry Street Newark, New Jersey 07109
More informationCase 2:18-cv Document 1 Filed 07/10/18 Page 1 of 218 PageID: 1 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
Case 2:18-cv-11518 Document 1 Filed 07/10/18 Page 1 of 218 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING ARNSTEIN & LEHR LLP One Riverfront Plaza, Suite 1520 Newark, NJ 07102-5426 (973) 286-6700
More informationCase 1:16-cv UNA Document 1 Filed 10/13/16 Page 1 of 17 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:16-cv-00942-UNA Document 1 Filed 10/13/16 Page 1 of 17 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ASTELLAS PHARMA INC., ASTELLAS IRELAND CO., LTD., and ASTELLAS
More informationCase 1:18-cv UNA Document 1 Filed 03/27/18 Page 1 of 87 PageID #: 4 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00466-UNA Document 1 Filed 03/27/18 Page 1 of 87 PageID #: 4 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE GILEAD SCIENCES, INC. and GILEAD PHARMASSET LLC, Plaintiffs, v.
More informationIN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION COMPLAINT FOR PATENT INFRINGEMENT
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION GALDERMA LABORATORIES, L.P., GALDERMA S.A., and GALDERMA RESEARCH & DEVELOPMENT, S.N.C., v. Plaintiffs, ACTAVIS MID
More informationCase 3:14-cv MLC-TJB Document Filed 07/24/15 Page 2 of 16 PageID: 1111 TABLE OF CONTENTS INTRODUCTION... 1 BACKGROUND...
Case 3:14-cv-02550-MLC-TJB Document 100-1 Filed 07/24/15 Page 1 of 16 PageID: 1110 Keith J. Miller Michael J. Gesualdo ROBINSON MILLER LLC One Newark Center, 19th Floor Newark, New Jersey 07102 Telephone:
More informationCase 2:15-cv WHW-CLW Document 1 Filed 08/31/15 Page 1 of 145 PageID: 1
Case 2:15-cv-06541-WHW-CLW Document 1 Filed 08/31/15 Page 1 of 145 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520 Newark, New Jersey 07102-5426 (973) 286-6700
More informationCase 3:15-cv MAS-LHG Document 1 Filed 04/06/15 Page 1 of 38 PageID: 1
Case 3:15-cv-02520-MAS-LHG Document 1 Filed 04/06/15 Page 1 of 38 PageID: 1 Liza M. Walsh, Esq. CONNELL FOLEY LLP 85 Livingston Avenue Roseland, New Jersey 07068-1765 (973) 535-0500 Of Counsel: William
More informationCase 1:10-cv UNA Document 1 Filed 10/25/10 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) ) ) ) ) ) ) ) ) ) ) )
Case 1:10-cv-00912-UNA Document 1 Filed 10/25/10 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ABBOTT LABORATORIES and WISCONSIN ALUMNI RESEARCH FOUNDATION, v. Plaintiffs,
More informationHOGAN & HARTSON APR -9 P4 :18 BY HAND DELIVERY
HOGAN & HARTSON 2741 10 APR -9 P4 :18 Hogan & Hartson up Columbia Square 555 Thirteenth Street, NW Washington, DC 20004 +1.202.637.5600 Tel +1.202.637.5910 Fax www.hhlaw.com Philip Katz Partner 202.637.5632
More informationCase 1:11-cv RGA Document 10 Filed 01/13/12 Page 1 of 14 PageID #: 47
Case 1:11-cv-01105-RGA Document 10 Filed 01/13/12 Page 1 of 14 PageID #: 47 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE WARNER CHILCOTT COMPANY, LLC, v. Plaintiff, ZYDUS PHARMACEUTICALS
More informationCase 6:18-cv ADA Document 26 Filed 01/11/19 Page 1 of 13 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS WACO DIVISION
Case 6:18-cv-00055-ADA Document 26 Filed 01/11/19 Page 1 of 13 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS WACO DIVISION RETROLED COMPONENTS, LLC, Plaintiff, v. PRINCIPAL LIGHTING
More informationCase 1:17-cv UNA Document 1 Filed 04/13/17 Page 1 of 13 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:17-cv-00422-UNA Document 1 Filed 04/13/17 Page 1 of 13 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MILLENNIUM PHARMACEUTICALS, INC. v. Plaintiff, AMNEAL PHARMACEUTICALS
More informationUNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WISCONSIN ) ) ) ) ) ) ) ) ) )
Apple, Inc. v. Motorola, Inc. et al Doc. 5 UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WISCONSIN APPLE INC. v. Plaintiff, MOTOROLA, INC. and MOTOROLA MOBILITY, INC. Defendants. ) ) ) ) ) )
More informationCase 1:16-cv UNA Document 1 Filed 03/31/16 Page 1 of 12 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:16-cv-00207-UNA Document 1 Filed 03/31/16 Page 1 of 12 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE GALDERMA LABORATORIES, L.P.; NESTLÉ SKIN HEALTH S.A.; and TCD
More informationCase 1:14-cv SLR-SRF Document 61 Filed 05/22/15 Page 1 of 20 PageID #: 634 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:14-cv-01083-SLR-SRF Document 61 Filed 05/22/15 Page 1 of 20 PageID #: 634 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UCB, INC., UCB MANUFACTURING IRELAND LIMITED, UCB PHARMA
More informationCase 3:16-cv MAS-LHG Document 1 Filed 09/16/16 Page 1 of 14 PageID: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 3:16-cv-05678-MAS-LHG Document 1 Filed 09/16/16 Page 1 of 14 PageID: 1 Liza M. Walsh Tricia B. O Reilly Katelyn O Reilly WALSH PIZZI O REILLY FALANGA LLP 1037 Raymond Boulevard, Suite 600 Newark,
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) ) ) ) ) ) ) ) ) ) ) ) ) ) COMPLAINT FOR PATENT INFRINGEMENT
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UCB, INC., UCB MANUFACTURING IRELAND LIMITED, UCB PHARMA GMBH, and LTS LOHMANN THERAPIE-SYSTEME AG, v. Plaintiffs. ZYDUS WORLDWIDE DMCC,
More informationUNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA, SAN FRANCISCO
Case:-cv-0-JSW Document Filed0// Page of 0 0 J. Rick Taché (#00) rtache@swlaw.com Deborah S. Mallgrave (#0) dmallgrave@swlaw.com Harsh P. Parikh (#0) hparikh@swlaw.com SNELL & WILMER Costa Mesa, CA - Telephone:
More informationCase 1:07-cv MRB Document 6 Filed 11/06/2007 Page 1 of 9 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO WESTERN DIVISION
Case 1:07-cv-00852-MRB Document 6 Filed 11/06/2007 Page 1 of 9 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO WESTERN DIVISION ESCORT, INC., Plaintiff, V. COBRA ELECTRONICS CORPORATION,
More informationIN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION
MANTIS COMMUNICATIONS, LLC, IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION v. Plaintiff, CULVER FRANCHISING SYSTEM, INC., CASE NO. 2:17-cv-324 PATENT CASE JURY
More informationPENDING LEGISLATION REGULATING PATENT INFRINGEMENT SETTLEMENTS
PENDING LEGISLATION REGULATING PATENT INFRINGEMENT SETTLEMENTS By Edward W. Correia* A number of bills have been introduced in the United States Congress this year that are intended to eliminate perceived
More informationCase: 1:10-cv Document #: 20 Filed: 04/11/11 Page 1 of 26 PageID #:217
Case: 1:10-cv-08050 Document #: 20 Filed: 04/11/11 Page 1 of 26 PageID #:217 FIRE 'EM UP, INC., v. IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION Plaintiff,
More informationCourthouse News Service
-\ IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA PICTURE PATENTS, LLC, ) ) \.L Plaintiff, ) ) Civil Case No. j.'o&cv o?&>4' MONUMENT REALTY LLC, ) JURY TRIAL DEMANDED ) Defendant.
More informationCase 1:16-cv Document 1 Filed 03/04/16 Page 1 of 6 PageID #: 1
Case 1:16-cv-00065 Document 1 Filed 03/04/16 Page 1 of 6 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS BEAUMONT DIVISION PRAXAIR, INC., PRAXAIR TECHNOLOGY, INC. Plaintiffs,
More informationAn ANDA Update. June 2004 Bulletin 04-50
June 2004 Bulletin 04-50 If you have questions or would like additional information on the material covered in this Bulletin, please contact one of the authors: Mark R. Shanks 202.414.9201 mshanks@reedsmith.com
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA. ) ) ) ) ) ) ) ) ) ) ) Plaintiffs, ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) Defendants.
Case 1:16-cv-01350 Document 1 Filed 06/28/16 Page 1 of 19 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA LANNETT COMPANY, INC., 13200 Townsend Road, Philadelphia, PA 19154 and LANNETT
More informationA. ANDAs and Eligibility for 180-day Exclusivity
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD 20857 SENT VIA ELECTRONIC MAIL Dear Celecoxib ANDA Applicant: This letter addresses the legal and regulatory scheme governing
More informationo 1205 Culbreth Dr., Suite 200, Wilmington, NC Phone : Facsimile :
Osmotica Pharmaceutical 1?54,Lt. 27 P2 :05 BY HAND DELIVERY Division of Dockets Management Food and Drug Administration Department of Health and Human Services 563"0 Fishers Lane, Room 1061 Rockville,
More informationCase 2:08-cv JLL-CCC Document 1 Filed 06/11/2008 Page 1 of 29 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 2:08-cv-02877-JLL-CCC Document 1 Filed 06/11/2008 Page 1 of 29 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY William J. Heller Jonathan M.H. Short McCARTER & ENGLISH, LLP Four
More informationCase 3:11-cv JAP -TJB Document 32 Filed 07/06/11 Page 1 of 19 PageID: 530 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 3:11-cv-03111-JAP -TJB Document 32 Filed 07/06/11 Page 1 of 19 PageID: 530 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY : NOSTRUM PHARMACEUTICALS, LLC, : : Plaintiff,
More informationCase 2:10-cv JLL -CCC Document 38 Filed 12/03/10 Page 1 of 36 PageID: 321 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 2:10-cv-05078-JLL -CCC Document 38 Filed 12/03/10 Page 1 of 36 PageID: 321 JASON B. LATTIMORE LATHAM & WATKINS LLP One Newark Center, 16 th Floor Newark, New Jersey 07102-3174 Telephone: 973.639.1234
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit TEVA PHARMACEUTICALS USA, INC., THROUGH ITS GATE PHARMACEUTICALS DIVISION, Plaintiff-Appellant, v. EISAI CO., LTD. AND EISAI MEDICAL RESEARCH, INC.,
More informationCase 3:13-cv M Document 60 Filed 12/19/14 Page 1 of 20 PageID 1778
Case 3:13-cv-04987-M Document 60 Filed 12/19/14 Page 1 of 20 PageID 1778 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION ILIFE TECHNOLOGIES, INC., Plaintiff, v. NINTENDO
More informationCase 2:13-cv JRG-RSP Document 12 Filed 07/10/13 Page 1 of 8 PageID #: 104
Case 2:13-cv-00014-JRG-RSP Document 12 Filed 07/10/13 Page 1 of 8 PageID #: 104 PERSONAL AUDIO, LLC IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION v. Plaintiff,
More informationCase 1:16-cv UNA Document 1 Filed 04/19/16 Page 1 of 6 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE COMPLAINT
Case 1:16-cv-00275-UNA Document 1 Filed 04/19/16 Page 1 of 6 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE Boston Scientific Corporation and Boston Scientific Scimed, Inc.,
More informationCase3:12-cv VC Document21 Filed06/09/14 Page1 of 12
Case:-cv-0-VC Document Filed0/0/ Page of QUINN EMANUEL URQUHART & SULLIVAN, LLP David Eiseman (Bar No. ) davideiseman@quinnemanuel.com Carl G. Anderson (Bar No. ) carlanderson@quinnemanuel.com 0 California
More informationUNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS TEXARKANA DIVISION
ESN LLC v. Cisco Systems, Inc. et al Doc. 9 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS TEXARKANA DIVISION ESN, LLC, v. Plaintiff, CISCO SYSTEMS, INC. and CISCO-LINKSYS, LLC, CIVIL ACTION NO.
More informationCase 1:18-cv Document 1 Filed 03/27/18 Page 1 of 12 PageID #: 1
Case 1:18-cv-01866 Document 1 Filed 03/27/18 Page 1 of 12 PageID #: 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK --------------------------------------------------------X AURORA LED TECHNOLOGY,
More informationUNITED STATES DISTRICT COURT DISTRICT OF NEW HAMPSHIRE
UNITED STATES DISTRICT COURT DISTRICT OF NEW HAMPSHIRE Archer Mobility Products, LLC, Plaintiff, v. Civil Action No. Penco Medical, Inc., DEMAND FOR JURY TRIAL Defendant. ARCHER MOBILITY PRODUCTS, LLC
More informationCase 1:18-cv UNA Document 1 Filed 10/22/18 Page 1 of 14 PageID #: 1
Case 1:18-cv-01639-UNA Document 1 Filed 10/22/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MILLENNIUM PHARMACEUTICALS, INC., v. Plaintiff, HETERO LABS LIMITED
More informationCase 1:16-cv AKH Document 1 Filed 04/25/16 Page 1 of 21. Case No.
Case 1:16-cv-03026-AKH Document 1 Filed 04/25/16 Page 1 of 21 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK RAB LIGHTING INC., v. Plaintiff, ABB LIGHTING, INC., GENERPOWER (SHANGHAI) CO.,
More informationIff/]) FEB Gregory 1. Glover Pharmaceutical Law Group PC 900 Seventh Street, NW Suite 650 Washington, DC
DEPARTMENT OF HEALTH &. HUMAN SERVICES FEB 2 2 2011 Food and Drug Administration Rockville MD 20857 Gregory 1. Glover Pharmaceutical Law Group PC 900 Seventh Street, NW Suite 650 Washington, DC 20001-3886
More informationIN THE UNITED STATES DISTRICT COURT FOR TH EASTERN DISTRICT OF TEXAS MARSHALL DIVISION. Plaintiff, Civil Action No. 2:15-cv-1294 v.
IN THE UNITED STATES DISTRICT COURT FOR TH EASTERN DISTRICT OF TEXAS MARSHALL DIVISION CRYPTOPEAK SOLUTIONS, LLC, Plaintiff, Civil Action No. 2:15-cv-1294 v. CHARLES SCHWAB & CO., INC., JURY TRIAL DEMANDED
More informationCase 9:16-cv RLR Document 1 Entered on FLSD Docket 04/15/2016 Page 1 of 6
Case 9:16-cv-80588-RLR Document 1 Entered on FLSD Docket 04/15/2016 Page 1 of 6 SHIPPING and TRANSIT, LLC, IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF FLORIDA vs. Plaintiff, STATE
More informationCase3:12-cv VC Document46 Filed01/12/15 Page1 of 5
Case:-cv-0-VC Document Filed0// Page of 0 JAMES C. OTTESON, State Bar No. jim@agilityiplaw.com THOMAS T. CARMACK, State Bar No. tom@agilityiplaw.com AGILITY IP LAW, LLP Commonwealth Drive Menlo Park, CA
More informationCaraco V. Novo Nordisk: Antitrust Implications
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Caraco V. Novo Nordisk: Antitrust Implications Law360,
More informationTHE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION Case No: 5:11-cv ) ) ) ) ) ) ) ) ) )
THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION Case No: 5:11-cv-00296 VEOLIA WATER SOLUTIONS & TECHNOLOGIES SUPPORT, v. Plaintiff, SIEMENS INDUSTRY, INC.,
More informationPATENT, TRADEMARK & COPYRIGHT!
A BNA s PATENT, TRADEMARK & COPYRIGHT! JOURNAL Reproduced with permission from BNA s Patent, Trademark & Copyright Journal, 81 PTCJ 36, 11/05/2010. Copyright 2010 by The Bureau of National Affairs, Inc.
More informationUNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS TYLER DIVISON COMPLAINT FOR PATENT INFRINGEMENT THE PARTIES
Case 6:07-cv-00492-LED Document 1 Filed 10/23/2007 Page 1 of 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS TYLER DIVISON Trent West, Plaintiff, v. Target Corporation, and Helzberg Diamond Shops,
More informationUNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA DEMAND FOR JURY TRIAL
MITCHELL + COMPANY Brian E. Mitchell (SBN 0) brian.mitchell@mcolawoffices.com Marcel F. De Armas (SBN ) mdearmas@mcolawoffices.com Embarcadero Center, Suite 00 San Francisco, California 1 Tel: -- Fax:
More informationWe have carefully considered the Petition.! For the reasons described below, the Petition is granted.
DEPARTMENT OF HEALTH &. HUMAN SERVICES... -------------_._- Food and Drug Administration Rockville MD 20857 JUN 17 2010. Pankaj Dave, Ph.D. Vice President, Regulatory Affairs Navinta LLC 1499 Lower Ferry
More informationTeva Pharmaceuticals USA Attention: Scott Tomsky Vice President, U.S. Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044
DEPARTMENT OF HEALTH & HUMAN SERVICES ANDA 091028 Food and Drug Administration Silver Spring, MD 20993 Teva Pharmaceuticals USA Attention: Scott Tomsky Vice President, U.S. Generics Regulatory Affairs
More informationThe Balance Between Innovation and Competition: The Hatch- Waxman Act, the 2003 Amendments, and Beyond
The Balance Between Innovation and Competition: The Hatch- Waxman Act, the 2003 Amendments, and Beyond The Harvard community has made this article openly available. Please share how this access benefits
More informationORDER GRANTING IN PART AND DENYING IN PART MOTION TO TRANSFER OR STAY
Pfizer Inc. et al v. Sandoz Inc. Doc. 50 Civil Action No. 09-cv-02392-CMA-MJW IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Christine M. Arguello PFIZER, INC., PFIZER PHARMACEUTICALS,
More informationCase 1:06-cv JJF Document 1 Filed 05/03/06 Page 1 of 14 PageID #: 224 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:06-cv-00291-JJF Document 1 Filed 05/03/06 Page 1 of 14 PageID #: 224 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE BROADBAND TECHNOLOGY INNOVATIONS, LLC, and PIE SQUARED LLC,
More informationCase 3:07-cv SI Document 25 Filed 11/26/2007 Page 1 of 7
Case :0-cv-0-SI Document Filed //0 Page of 0 JEFFREY S. BUCHOLTZ Acting Assistant Attorney General CARL J. NICHOLS Deputy Assistant Attorney General SCOTT N. SCHOOLS United States Attorney ELIZABETH J.
More informationUNITED STATES DISTRICT COURT DISTRICT OF NEVADA
0 RICHARD G. CAMPBELL, JR. Nevada Bar No.: ARMSTRONG TEASDALE, LLP 0 West Liberty Street, Suite 0 Reno, Nevada 0 Telephone No.: () -00 Facsimile No.: () -0 Email: rcampbell@armstrongteasdale.com JENNIFER
More informationIN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS TEXARKANA DIVISION ) ) ) ) ) ) ) ) COMPLAINT FOR PATENT INFRINGEMENT
Case 5:07-cv-00156-DF-CMC Document 1-1 Filed 10/15/2007 Page 1 of 6 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS TEXARKANA DIVISION ESN, LLC, v. Plaintiff, CISCO SYSTEMS, INC.,
More informationIN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION, AKRON
- - 0 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION, AKRON Pain Management Technologies, Inc., ) 0 Home Ave., Bldg. A ) Case No. Akron, Ohio 0, ) ) Judge Plaintiff,
More informationUNITED STATES DISTRICT COURT DISTRICT OF IDAHO. No.
Case :-cv-00-blw Document Filed // Page of CHRISTOPHER G. VARALLO, ISB # Witherspoon Kelley West Riverside Avenue, Suite 00 Spokane, Washington Telephone: (0) Facsimile: (0) cgv@witherspoonkelley.com Counsel
More informationUnited States Court of Appeals for the Federal Circuit
Case: 14-1282 Case: CASE 14-1282 PARTICIPANTS Document: ONLY 44 Document: Page: 1 43 Filed: Page: 05/30/2014 1 Filed: 05/30/2014 2014-1282, -1291 United States Court of Appeals for the Federal Circuit
More informationCase 2:10-cv WHW-CLW Document 804 Filed 03/26/14 Page 1 of 5 PageID: 47723
Case 2:10-cv-05954-WHW-CLW Document 804 Filed 03/26/14 Page 1 of 5 PageID: 47723 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY JANSSEN PRODUCTS, L.P. et al., Plaintiffs, : C.A. No.
More informationTHE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION Case No: 5:15-cv-590 ) ) ) ) ) ) ) ) ) )
THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION Case No: 5:15-cv-590 VEOLIA WATER SOLUTIONS & TECHNOLOGIES SUPPORT, v. Plaintiff, WESTECH ENGINEERING, INC.,
More informationCase 3:10-cv FLW-DEA Document 48 Filed 09/27/11 Page 1 of 10 PageID: 1147 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 3:10-cv-05695-FLW-DEA Document 48 Filed 09/27/11 Page 1 of 10 PageID: 1147 Edward R. Mackiewicz STEPTOE & JOHNSON LLP 1330 Connecticut Avenue, NW Washington, D.C. 20036 Telephone: 202-429-6412 Facsimile:
More informationCase 6:15-cv Document 1 Filed 01/13/15 Page 1 of 6 PageID #: 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS TYLER DIVISION COMPLAINT
Case 6:15-cv-00042 Document 1 Filed 01/13/15 Page 1 of 6 PageID #: 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS TYLER DIVISION ADAPTIX, INC., Plaintiff, v. ERICSSON, INC., TELEFONAKTIEBOLAGET
More information2010 Thomson Reuters. No Claim to Orig. US Gov. Works.
Page 1 United States Court of Appeals, Federal Circuit. CARACO PHARMACEUTICAL LABORATO- RIES, LTD., Plaintiff-Appellant, v. FOREST LABORATORIES, INC., Forest Laboratories Holdings, Ltd., and H. Lundbeck
More informationFrom PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888
From PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888 New Strategies Arising From the Hatch-Waxman Amendments Practicing Law Institute Telephone Briefing May 12, 2004 I. INTRODUCTION
More informationUNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION COMPLAINT FOR DECLARATORY JUDGMENT OF NON-INFRINGEMENT AND INVALIDITY
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION MEDICINE STORE PHARMACY, INC. d/b/a RXPRESS PHARMACY, CASE NO. 3:14-cv-2255 Plaintiff, v. JURY TRIAL DEMANDED AFGIN PHARMA LLC, Defendant.
More informationUNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA
Case :-cv-00 Document Filed 0// Page of 0 Page ID #: 0 Randall J. Sunshine (SBN ) rsunshine@linerlaw.com Ryan E. Hatch (SBN ) rhatch@linerlaw.com Jason L. Haas (SBN 0) jhaas@linerlaw.com LINER LLP 00 Glendon
More information